ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis
The purpose of this study is to assess the efficacy, safety and pharmacokinetics of maintenance treatment with 3mg/kg, 6mg/kg or 10mg/kg of TA-650 in combination with methotrexate (MTX) after three infusions (weeks-0, 2, 6) of 3mg/kg in Rheumatoid Arthritis (RA) showing an insufficient response to MTX.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes#847870
- Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.#873132
- Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)#1139914
- Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis#1095250
- A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis#912551
Record · ID 1047013
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive